§Úªº³Ì·R ³]¬°­º­¶ Ápµ¸§Ú­Ì
¡»¸Ü²á­Ñ¼Ö³¡ | ¡»¤å³¹·j¯Á | ¡»¤Í¯¸³sµ² | ¡»¯d¨¥&µo°Ý°Ï | ¡»³¯Â@¶hÂå®v²¤¶ | ¡»¼v­µe¾Ç­b-¥Á²³ª© | ¡»¼v­µe¾Ç­b-ÂåÅ@ª© | ¡»Àù¯gÃĪ«ªvÀøÁ¿®y
>­º­¶ -> Àù¯g§K¬ÌªvÀø·sÁÍ¶Õ -> §K¬ÌÀˬdÂI§í¨î¾¯ -> Atezolizumab(Tecentriq)

TOP

TECENTRIQ® ¡]atezolizumab¡^: ±ß´Á«D¤p²Ó­MªÍÀùªºPD-L1§K¬ÌÀˬdÂI§í¨î¾¯
[ µo¥¬ªÌ:³¯Â@¶h | ®É¶¡:2016-10-24 23:10:40 | §@ªÌ:³¯Â@¶hÂå®v | ¨Ó·½: | ÂsÄý:4617¦¸ ]

2016 ¦~ 10 ¤ë 18 ¤é·sªºªÍÀù§K¬ÌªvÀøÃĪ« TECENTRIQ® ¡]atezolizumab¡^³q¹L¬ü°êFDA ®Ö­ã¡CTECENTRIQ®¤D¹B¥Î§K¬Ì¨t²Îªº­«·s¬¡¤Æ¨Ó§í¨îÀù²Ó­M¥Íªø¡A¾A¥Î©óÂಾ©Ê«D¤p²Ó­MªÍÀù¥B¨Ï¥Î¤ÆÀø©Î¼Ð¹vªvÀøµL®Äªº±wªÌ¡C

 

TECENTRIQ ¦bÀù¯g§K¬ÌÀøªk¤¤ÄÝ©ó§K¬ÌÀˬdÂI§í¨î¾¯ªº¤@ºØ¡A¥»¨­¬O¤@ºØ³æ®è§ÜÅé¡A³z¹L»PÀù²Ó­M©M¸~½F¤º®û¼í²O¤Ú²y²Ó­Mªí­±ªº§K¬ÌÀˬdÂI³J¥Õ½è PD-L1 µ²¦X¡A¶i¦ÓªýÂ_ PD-1 ©M B7.1 ¨üÅ骺¥æ¤¬§@¥Î¡A¥´À»Àù²Ó­M¥Íªø¡C¥Ø«e¸ÓÃĪ«¥D­n¥Î©óÂಾ©Ê«D¤p²Ó­MªÍÀù¡B¦Ó¥B¤w¸g±µ¨ü§t¹`¤§¤ÆÀøÃĪ«¦ýµL®Ä¡A¥H¤Î ­Y¦³EGFR ©Î ALK °ò¦]²§±`¥B¨Ï¥Î¬Û¹ïÀ³¼Ð¹vªvÀø¯f±¡¤´¤£¨£§ïµ½ªÌ¡C

 

TECENTRIQ ¬O²Ä¤@­Ó¡B¤]¬O¥Ø«e°ß¤@®Ö­ãªºPD-L1Àù¯g§K¬ÌªvÀøÃĪ«¡A°w¹ïÀù²Ó­M©M¸~½F¤º®û¼í²O¤Ú²y²Ó­Mªí­±ªº§K¬ÌÀˬdÂIªºPD-L1 ³J¥Õ¶i¦æªýÂ_§@¥Î¡C¥BµL½×±wªÌªº PD-L1¤§¤ô¥­ªí²{¦p¦ó¡ATECENTRIQ³£¯àµo´§§@¥Î¡A®ÄªG¤]¤ñ²Ä¤G½u¤§¼Ð·Ç¤ÆÀø§ó¦n¡C

 

®Ú¾Ú¥Ø«e¥þ²y³Ì¤jTECENTRIQªº²Ä¤T´ÁÁ{§É¸ÕÅçOAK¡A¨ä¬ã¨sµ²ªGÅã¥Ü¨Ï¥Î TECENTRIQ ªº±wªÌ¥­§¡¦s¬¡®É¶¡¬°13.8­Ó¤ë¡A¬Û¸û©ó¨Ï¥Î²Ä¤G½u¤§¼Ð·Ç¤ÆÀø Docetaxelªº±wªÌ¦h¤F 4.2­Ó¤ëªº®É¶¡¡C

 

¹L¥h 15 ¦~¨Ó¡A±ß´Á«D¤p²Ó­MªÍÀùªº¦s¬¡²v¤@ª½¤£Â_´£¤É¡A¦ÓTECENTRIQ ªº®Ö­ã¹ï«D¤p²Ó­MªÍÀù¯f±w¨Ó»¡¬O«D±`­«­nªº¬ð¯}¡A¦]¬°¥¦´£¨Ñ¤F±ß´Á«D¤p²Ó­MªÍÀùªvÀøªº¤@¶µ·s¿ï¾Ü¡C

 

¥Ñ©ó TECENTRIQ ¬O³z¹L§í¨î PD-L1 ªºªí²{¡A¨Ó¬¡¤ÆÅ餺ªºT²Ó­M¨Ó¹ï§ÜÀù²Ó­M¡A¦]¦¹TECENTRIQ¤]¥i¯à¾É­P¥¿±`²Ó­M¨ü·l¡C±`¨£ªº°Æ§@¥Î¦³¯h¾Î¡B­¹±ý¤£®¶¡B©I§lµu«P¡Bäú¤ß¤Î«K¯µµ¥¯gª¬¡A¦ý¤]¥i¯à¤Þµo¸ûÄY­«ªºªÍª¢¡B¨xª¢¡B¤º¤Àªc¥¢½Õ¡B¯«¸g¤Î²´³¡¬ÛÃö¯e¯fµ¥¡C

 





  



³¯Â@¶hÂå®v¥Ø«e¾á¥ôÀù¯g¤¤Âå»P¦èÂåÁ{§ÉªvÀøÂå®v¡AµÛ¦³¡¨À»°hÀù¯h¾Î Âå®v¸Ó§i¶D§AªºÀù«á¾i¥Í³N¡¨(±d°·¥Xª©)¡A±M¾¤¤¦èÂåµ²¦XÀù¯gªvÀø»PÀù¤ÍÃöÃh¤§¤½¯q¬¡°Ê¡A¦P®É¼ö¤ß­P¤O©ó¥¿½TÀù¯g·ÓÅ@¸ê°T¤§±À¼s»P¶Ç»¼¡A¨ä©Ò³Ð«Ø¤§¥x¤¤¥«¥þ¤è¦ìÀù¯gÃöÃh¨ó·|(http://www.cancerinfotw.org )¡A¤D¬O±M·~·ÓÅ@¤H­û¡BªÀ·|½å¹F°^Äm©Ò¾Ç¡A©Ò«ØºcªºÀù¯g¶EÀø»P·ÓÅ@¸ê°T¥­»O¡C

¦¹³B¤å³¹¤D¬OÂåÀø·ÓÅ@¸ê°Tªº¾ã²z¡A½Ð¤Å¤Þ¾Ú¤å³¹¤º®e¦Û¦æ±Ä¨úÂåÀø¨M©w¡F¦p¦³Á{§ÉªvÀø¤§»Ý¨D¡A«ØÄ³ÁÙ¬OÀ³¸Ó´M¨D±M·~ÂåÀø¤H­ûªº¨ó§U¡C¦p¦³¥ô¦óÂÕ»~©Î«ØÄ³¡AÀµ½Ð¤£§[«ü±Ð¡C

»Ý­n¾\Äý§@ªÌ¼¶¼gªº§ó¦h¬ÛÃöÀù¯g¸ê°T¡AÅwªï«e©¹³¯Â@¶hÂå®v©xºô¡¨¸Ü²á­Ñ¼Ö³¡¡¨ http://cancerfree.medicalmap.tw/alonepage.php?id=7

 

§ó¦h½u¤W½ÍÀù¯g§K¬ÌªvÀø·s¸ê°T¡A½Ð³s±µ

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/418-2016-02-27-18-42-09

    ±q¶Ç²Î§K¬Ì«äºû½Í·í¥N³ÌÉqªºÀù¯g§K¬ÌªvÀø

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/419-2016-02-27-18-55-49

    ÂåÀø¤j¬ð¯} Àù¯g§K¬ÌÃĪ«ªvÀø

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/421-2016-02-27-19-16-05

    ¦A¤U¤@«°:ªÍÀù§K¬ÌÃĪ«ªvÀø

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/692-2016-09-02-09-45-01

    Àù¯g§K¬ÌªvÀø¾Ç¤§¤¶²Ð»P¨äÀ³¥Î©óªÍÀùªvÀøªº·s¶i®i

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/420-2016-02-27-19-12-58

    ªï¦VÀÆ¥ú:¶Â¦â¯À½F§K¬ÌÃĪ«ªvÀø

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/695-2016-09-02-10-42-28

    »{ÃÑÀù¯g§K¬ÌªvÀøªº¤£¨}¤ÏÀ³»P³B¸m

l          http://www.cancerinfotw.org/index.php/e-e-learning/2015-09-13-10-21-48/696-2016-09-02-10-50-26

    §K¬ÌÆ[ÂI¬Ý¤¤Â廲§UªvÀøªÍÀù


·q½Ð¼ö¯PÅTÀ³»O¤¤¥«¥þ¤è¦ìÀù¯gÃöÃh¨ó·|Á|¿ì¤§¡¨®½µ½´ÚÃØ¤¸®ð¾i¥Í¯ù¬¡°Ê¡¨¡C

ªÀ·|¤WÃöÃhÀù¤Íªºµ½¤ß¤H¤h¤Z©ó¬¡°Ê´Á¶¡(2016¦~6¤ë¦Ü2017¦~12¤ë)¡A³æµ§®½´Ú¹F·s¥x¹ô1,000¤¸¥H¤W¡A±N­PÃØ¥»·|ºë¤ß»s§@¤§¤¸®ð¾i¥Í¯ù1²°¡C¤¸®ð¾i¥Í¯ùªº»s§@¡A«Y°Ñ¦Ò³¯Â@¶hÂå®v©ÒµÛ¡¨À»°hÀù¯h¾Î¡GÂå®v¸Ó§i¶D§AªºÀù«á¾i¥Í³N¡¨¡A ¥B¿ï¥Î¦w¤ßÃħ÷¬Ò«Y100%¯Â¤ÑµM¯À§÷¡A¦X¥G°ê»Ú¯ÅICP­«ª÷ÄÝ¡BGC¹AÃĴݯd¡B·L¥Íª«ÀËÅç¦X®æ¡C

½Ð¦Ü¥þ°ê¦U®a»È¦æ¶×´Ú¡A¶×´Ú³æ¼v¦L¥»½Ðµù©ú±zªº©m¦W¡B¦a§}¡BÁpµ¸¹q¸Ü¶l±H¦Ü¥»·|(¥x¤¤¥«¤j¸Ì°Ï²n¤å¸ô1181¸¹)¡A¥H¤è«K§Ú­Ì¶}¥ß¦¬¾Úµ¹±z¡C

»È¦æ¦WºÙ¡G¥üÂ×°ê»Ú°Ó·~»È¦æ ¤¤¥x¤¤¤À¦æ¡@ »È¦æ¥N¸¹¡G017    

±b¸¹¡G204-09-80512-0¡@

 

[¤W¤@½g]9 ¤ë²Ä¤@Ãz PD-L1§K¬ÌÃĪ«Atezol.. [¤U¤@½g]»H¯ÖÀùPD-L1§K¬Ì·sÃIJĤ@½uªvÀøªº..

 
±À¨ì Facebook!
±À¨ì Twitter!
±À¨ì Plurk!

¬ÛÃöÄæ¥Ø

³Ì·s¤å³¹

¼öªù¤å³¹

±ÀÂˤ峹

¤Í¯¸³sµ²

¤¤¥¡°·«O§½
°ê®aºô¸ôÂå°|
§ÜÀù¦³±s¦u ¥Í©R¦V«e¨« ³¯Âå®v»P§A¦A³y°·±d